Cargando…

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder

BACKGROUND: Major depressive disorder (MDD) significantly impacts performance of both work- and nonwork-related routine daily activities. We have shown that work productivity is significantly impaired in employed MDD patients, but the extent of impairments in nonwork-related routine activities and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jha, Manish K, Teer, Raymond B, Minhajuddin, Abu, Greer, Tracy L, Rush, A John, Trivedi, Madhukar H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359139/ https://www.ncbi.nlm.nih.gov/pubmed/28352180 http://dx.doi.org/10.2147/NDT.S128407

Ejemplares similares

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
por: Jha, Manish K., et al.
Publicado: (2016)

Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale
por: Jha, Manish K, et al.
Publicado: (2017)

Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
por: Jha, Manish K, et al.
Publicado: (2017)

Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
por: Jha, Manish K., et al.
Publicado: (2019)

Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
por: Jha, Manish K, et al.
Publicado: (2019)

Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?
por: Greer, Tracy L., et al.
Publicado: (2014)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study
por: Minhajuddin, Abu, et al.
Publicado: (2020)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
por: Berman, Robert M, et al.
Publicado: (2011)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory
por: Mason, Brittany L., et al.
Publicado: (2022)

An electroencephalographic signature predicts antidepressant response in major depression
por: Wu, Wei, et al.
Publicado: (2020)

Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020)

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study
por: Chin Fatt, Cherise R., et al.
Publicado: (2023)

A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007)

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients
por: Martín-López, Luis M., et al.
Publicado: (2011)

Immune characterization of suicidal behavior in female adolescents
por: Chin Fatt, Cherise R., et al.
Publicado: (2022)

VitalSign(6): A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression
por: Trivedi, Madhukar H., et al.
Publicado: (2019)

Brain Regulation of Emotional Conflict Predicts Antidepressant Treatment Response for Depression
por: Fonzo, Gregory A., et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on adults with current and prior depression: initial findings from the longitudinal Texas RAD study
por: Czysz, Andrew H., et al.
Publicado: (2021)

Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II
por: Baldessarini, Ross J., et al.
Publicado: (2016)

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
por: Safer, Daniel J., et al.
Publicado: (2019)

Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
por: Ho, Siew Ching, et al.
Publicado: (2017)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study
por: Papakostas, George I., et al.
Publicado: (2020)

Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach
por: South, Charles, et al.
Publicado: (2017)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder
por: Korgaonkar, Mayuresh S., et al.
Publicado: (2014)

Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis
por: Shinohara, Kiyomi, et al.
Publicado: (2019)

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2018)

Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report
por: Braund, Taylor A., et al.
Publicado: (2021)

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2019)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Item response analysis of the inventory of depressive symptomatology
por: Bernstein, Ira H, et al.
Publicado: (2006)

Effect of income level on adherence to antidepressant treatment in first onset depression outpatients
por: Ji, Nam-Ju, et al.
Publicado: (2020)

Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs
por: Sharpe, M, et al.
Publicado: (2004)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response
por: Hervé, Mylène, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f7qpbta4uh31e53s8q2v40dm8c